Hongsheng Lin
- Molecular Biology
- Oncology
- Immunology
- Complementary and alternative medicine top 5%
- Pharmacology top 10%
- Topics
- Plant-based Medicinal Research (6 papers)Cancer survivorship and care (5 papers)Cancer Cells and Metastasis (4 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Hongsheng Lin
42 papers receiving 685 citations
Peers
Comparison fields: 5 of 99
- Molecular Biology 293
- Oncology 147
- Immunology 145
- Complementary and alternative medicine 127
- Pharmacology 117
Countries citing papers authored by Hongsheng Lin
This map shows the geographic impact of Hongsheng Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongsheng Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongsheng Lin more than expected).
Fields of papers citing papers by Hongsheng Lin
This network shows the impact of papers produced by Hongsheng Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongsheng Lin. The network helps show where Hongsheng Lin may publish in the future.
Co-authorship network of co-authors of Hongsheng Lin
This figure shows the co-authorship network connecting the top 25 collaborators of Hongsheng Lin. A scholar is included among the top collaborators of Hongsheng Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongsheng Lin. Hongsheng Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 3 | |
| 6 | 1 | |
| 7 | 14 | |
| 8 | 17 | |
| 9 | 19 | |
| 10 | 12 | |
| 11 | 20 | |
| 12 | 17 | |
| 13 | 12 | |
| 14 | 20 | |
| 15 | Clinical Research on Shenyi Capsule Combined with Gefitinib for Advanced Non-Small Cell Lung Cancer: A Report of 50 Cases | 5 |
| 16 | 15 | |
| 17 | 4 | |
| 18 | 11 | |
| 19 | 51 | |
| 20 | Phase II clinical trial report of treating lung cancer with Shen Yi Capsule | 4 |
About Hongsheng Lin
Hongsheng Lin is a scholar working on Pharmacology, Otorhinolaryngology and Oncology, having authored 46 papers that have together received 703 indexed citations. Recurring topics across this work include Plant-based Medicinal Research (6 papers), Cancer survivorship and care (5 papers) and Cancer Cells and Metastasis (4 papers). The work is most often cited by research in Complementary and alternative medicine (127 citations), Pharmacology (117 citations) and Periodontics (41 citations). Hongsheng Lin has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Jie Li, Qiujun Guo, J. Beuth, Harald Matthes, Wei Hou, Ulrich Mansmann, Baojin Hua, Weidong Li, Matthew R. Young and Nancy H. Colburn. Their work appears in journals such as Cancer Research, American Journal of Epidemiology and Chemical Engineering Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.